Device Trial Radar · NCT03818620
Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer
Last checked: Nov 21, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,339
Actual
Start
Jun 7, 2017
Primary completion
Jun 7, 2023
Study completion May 15, 2025
Sponsor
- Lead sponsor
- Barco NVNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 28, 2019
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter prospective observational clinical investigation with a medical device. The purpose of this study is to develop and validate of a new type of digital dermatoscope with automatic decision support algorithms. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to further improve the developed technology.
Conditions
- Skin Cancer
- Skin Diseases
Interventions
Barco digital dermatoscope device imagesDevice
Images of skin lesion taken with the Barco dermatoscope by site team member
Reference standard dermatoscope device imagesDevice
Images of skin lesion taken with a standard dermatoscope device (as part of standard care)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Development of anonymized database with over 3000 (potential) skin cancer cases for use in AITime frame: 3.5 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
UZ Gent
Ghent, Belgium
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.